Skip to main content

Mersana Therapeutics, Inc.

MRSNDelisted Jan 6, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001442836

Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.

Q4 2025 vs. Q3 2025

How the institutions holding Mersana Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of MRSN: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders4951+2
Shares3.18M2.24M−939.5K (−29.5%)
Value$24.7M$64.8M+$40.1M (+162.4%)

New holders (18)

Institutions that held Mersana Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to MRSN in Q4 2025
InstitutionSharesValue% of portfolio
Affinity Asset Advisors, LLC100,000$2.89M0.21%
Groupe la Francaise61,488$1.78M0.03%
Rangeley Capital, LLC57,098$1.65M1.42%
Gabelli Funds LLC47,300$1.37M0.01%
Credit Industriel Et Commercial41,392$1.20M0.17%
Yakira Capital Management, Inc.32,663$944.9K0.32%
Citadel Advisors LLC22,493$650.7K0.00%
Deltec Asset Management LLC18,000$520.7K0.09%
Knott David M Jr111,686$437.8K0.20%
XTX Topco Ltd11,948$345.7K0.01%
Point72 Asset Management, L.P.10,364$299.8K0.00%
Gamco Investors, Inc. Et Al10,000$289.3K0.00%
Northern Trust Corp8,586$248.4K0.00%
Omers Administration Corp7,900$228.5K0.00%
Equitec Proprietary Markets, LLC5,593$161.8K0.78%
Mint Tower Capital Management B.V.1,035$30.0K0.00%
Flagship Harbor Advisors, LLC76$2.20K0.00%
SHP Wealth Management25$7230.00%

Sold out (16)

Institutions that held Mersana Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.